Cargando…

Gene therapy in Alzheimer’s disease – potential for disease modification

Alzheimer’s disease (AD) is the major cause of dementia in the elderly, leading to memory loss and cognitive decline. The mechanism underlying onset of the disease has not been fully elucidated. However, characteristic pathological manifestations include extracellular accumulation and aggregation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nilsson, Per, Iwata, Nobuhisa, Muramatsu, Shin-ichi, Tjernberg, Lars O, Winblad, Bengt, Saido, Takaomi C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823109/ https://www.ncbi.nlm.nih.gov/pubmed/20158567 http://dx.doi.org/10.1111/j.1582-4934.2010.01038.x

Ejemplares similares

Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ(42)-Induced Pathways to Alzheimer’s Disease Pathology
por: Schedin-Weiss, Sophia, et al.
Publicado: (2020)

Recent Advances in the Modeling of Alzheimer’s Disease
por: Sasaguri, Hiroki, et al.
Publicado: (2022)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Dual roles for autophagy: Degradation and secretion of Alzheimer's disease Aβ peptide
por: Nilsson, Per, et al.
Publicado: (2014)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons
por: Yu, Yang, et al.
Publicado: (2021)

Amyloid Beta Annular Protofibrils in Cell Processes and Synapses Accumulate with Aging and Alzheimer-Associated Genetic Modification
por: Kokubo, Hideko, et al.
Publicado: (2009)

Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
por: Sandebring-Matton, Anna, et al.
Publicado: (2021)

An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
por: Kizuka, Yasuhiko, et al.
Publicado: (2015)

Analysis of microdissected neurons by (18)O mass spectrometry reveals altered protein expression in Alzheimer's disease
por: Hashimoto, Masakazu, et al.
Publicado: (2012)

Distinctive alteration of presynaptic proteins in the outer molecular layer of the dentate gyrus in Alzheimer’s disease
por: Haytural, Hazal, et al.
Publicado: (2021)

Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
por: SAIDO, Takaomi C.
Publicado: (2013)

Neuroinflammation in mouse models of Alzheimer's disease
por: Saito, Takashi, et al.
Publicado: (2018)

Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
por: Iwata, Nobuhisa, et al.
Publicado: (2013)

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology
por: Tanaka, Hikari, et al.
Publicado: (2018)

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
por: Schedin‐Weiss, Sophia, et al.
Publicado: (2020)

Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease
por: Hashimoto, Shoko, et al.
Publicado: (2018)

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment
por: Huang, Chaorui, et al.
Publicado: (2002)

The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease
por: Haytural, Hazal, et al.
Publicado: (2020)

Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice
por: Medina-Vera, Dina, et al.
Publicado: (2023)

γ-Secretase Dependent Production of Intracellular Domains Is Reduced in Adult Compared to Embryonic Rat Brain Membranes
por: Frånberg, Jenny, et al.
Publicado: (2010)

The rat as an animal model of Alzheimer’s disease
por: Benedikz, Eirikur, et al.
Publicado: (2009)

Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
por: Schedin-Weiss, Sophia, et al.
Publicado: (2017)

Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse
por: Schedin-Weiss, Sophia, et al.
Publicado: (2016)

Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons
por: Gao, Yang, et al.
Publicado: (2021)

Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
por: Yahata, Naoki, et al.
Publicado: (2011)

Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer’s Disease
por: Narukawa, Masataka, et al.
Publicado: (2020)

Monoamine oxidase B is associated with γ-secretase in cultured neurons and in brain
por: Weiss, Sophia Schedin, et al.
Publicado: (2013)

Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses
por: Yu, Yang, et al.
Publicado: (2018)

Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer’s Disease
por: Smailovic, Una, et al.
Publicado: (2021)

The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease
por: Gaunitz, Stefan, et al.
Publicado: (2020)

Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
por: Haytural, Hazal, et al.
Publicado: (2021)

Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer’s disease
por: Islam, Anam, et al.
Publicado: (2023)

Occludin is overexpressed in Alzheimer's disease and vascular dementia
por: Romanitan, Mihaela Oana, et al.
Publicado: (2007)

Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer’s disease brains
por: Sharoar, Md Golam, et al.
Publicado: (2021)

The need for thorough phase II studies in medicines development for Alzheimer’s disease
por: Gray, Julian A., et al.
Publicado: (2015)

Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer’s disease
por: Kloskowska, Ewa, et al.
Publicado: (2010)

Active immunotherapy options for Alzheimer’s disease
por: Winblad, Bengt, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gmd2g4sc4207sqclbiommeu50n